Cell-Innovations Pty Limited is an emerging leader in regenerative medicine
Cell-Innovations, based in Sydney, Australia, are international leaders in the field of Regenerative Medicine using autologous Stromal Vascular Fraction (SVF) obtained from your own body fat. The company engages in both clinical and basic science studies in the use of StroMed for clinical indications.
Cell-Innovations have developed proprietary technology which uses ultrasound cavitation to extract the adipose Stromal Vascular Fraction (SVF) with extra-cellular matrix from adipose tissue. Unlike other methods of SVF separation, the major advantage of using the Cell-Innovations process is the ease and speed of processing (within 40 minutes). Most significantly, there is no use of chemicals and enzymes, such as collagenase, making our process cleaner and safer.
Cell-Innovations technology does not isolate any particular cell or stem cell from the adipose tissue, nor does it culture cells. Stromal Vascular Fraction contains multiple cell types. Stromal Vascular Fraction therapy has been found to be beneficial, but cannot be considered a stem cell therapy as we do not culture the cells.
Cell-Innovations license the ultrasonic cavitation technology to doctors and clinicians throughout Australia and internationally.
Treatments are now available, via our licensed Medical Specialists. Your Medical Specialist will be able to advise you on the suitability of the treatment, and the likely chance of success.
How Cell-Innovations can help you
When investing in Cell-Innovations technology, our packages include comprehensive training, full laboratory and surgical equipment, ongoing support and assistance for extracting Stromal Vascular Fraction(SVF) from adipose tissue to treat your patients. By using Cell-Innovations you may be able to implement highly efficient technology that is cost effective and provides a much higher cell count compared to other traditional cell extraction technologies.
Stromal Vascular Fraction (SVF) are the building blocks of the body that promote healing and gives relief from pain.
With ground-breaking data, information and technology consistently becoming readily available to medical practitioners on a daily basis, it’s important for doctors worldwide to keep up to date with the latest in modern medical treatments. That is why understanding and implementing such innovative technology is a necessary step towards the future of medicine.
Discovering stromal cells and pericytes
Stromal cells and pericytes are found throughout all the tissues in body, and are also located in the fat tissue and bone marrow. There are a few different methods of refining and using these cells, but here at Cell-Innovations in Sydney we offer our clients the latest in innovative technology and training that assists in the extraction and restructuring of adipose tissue (commonly called fat) into Stromal Vascular Fraction (a mix of beneficial cells).
Why adipose tissue?
Both bone marrow and adipose tissue are common sources of Stromal Vascular Fraction (SVF), but adipose tissue is a much more accessible and replenish-able source of SVF than bone marrow.
How does the adipose tissue get extracted?
The adipose tissue is carefully removed through a mini-liposuction procedure. Then, with the right tools, technology and training, doctors are able to refine the adipose tissue to remove the adipose cells which are not required.
This process of refinement is called ultrasonic cavitation which removes the useless tissue from the adipose. The remaining cells are known as Stromal Vascular Fraction (SVF) cells and they are vital for treating joint pain.
Why choose Cell-Innovations technology?
As an efficient and cost effective alternative to lengthy, and comparatively risky, cultivating techniques and technologies used in the past, Cell-Innovations is able to provide a much greater cell count and viability essential to assist the healing process for the affected area.
Different technologies that separate out Stromal Vascular Fraction (SVF) may produce different outcomes,and that is why Cell-Innovations uses the term ‘StroMed’ to describe its particular type of SVF. The studies on StroMed are reported on this website.
What does it have to do with arthritis?
As a support to the repair and of tissue, StroMed is able to provide a stimulant to the affected area. If the patient was suffering from arthritis in the knee joint for example, the new cells would encourage reduced inflammation and pain, and aid in the repair of the joint. Generally within less than 10 days the patient should begin to see some results.
To find out more about the uses of Stromal Vascular Fraction (SVF) and how Cell-Innovations is committed to providing quality and up-to-date equipment and service, contact us on 1300 738 025 (or +61(2) 49100924 from outside Australia), and find out how your practice can provide ground breaking technology for your patients today.